Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion type Assertion NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_head.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion description "[Our results strongly support a role for PI3K/Akt/mTOR pathway in PET, which ties in with the fact that mTOR inhibitors have reached phase III trials in neuroendocrine tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_provenance.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion evidence source_evidence_literature NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_provenance.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion SIO_000772 19917848 NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_provenance.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion wasDerivedFrom befree-20150227 NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_provenance.
- NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_assertion wasGeneratedBy ECO_0000203 NP621440.RAnm6sdy3HTszSc8_nCy50e6sl6RdcKR2xoSX2xlxsdxc130_provenance.